Study of ATX-01 in Participants With DM1
Conditions
Myotonic Dystrophy 1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA, Los Angeles, California, United States
Contact: Principal Investigator (Perry Shieh, MD, PhD)University of Florida, Gainesville, Florida, United States
University of Iowa Health Care - Department of Neurology, Iowa City, Iowa, United States
Contact: Principal Investigator (Andrea Swenson)University of Kansas Medical Center, Department of Neurology, Fairway, Kansas, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Contact: Principal Investigator (Nicholas Johnson, MD)Centre Intégré Universitaire de Santé et Services Sociaux du Saguenay-Lac-St-Jean, Chicoutimi, Quebec, Canada
Institute of Myology, Paris, France
The NeMO Clinical Center in Milan, Neurorehabilitation Unit, University of Milan, Milan, Italy
Fondazione Policlinico A. Gemelli- IRCCS, Rome, Italy
Radboudumc, Nijmegen, Netherlands
Contact: Study coordinator (Spierziekten Research Team Radboudumc) · spierziektenresearchteam@radboudumc.nlContact: Principal Investigator (K Mul)Hospital Universitario Donostia, Donostia / San Sebastian, Spain
Contact: Principal Investigator (Adolfo López de Munain Arregui)St. George's University Hospital, London, United Kingdom
Contact: Principal Investigator (Emma Matthews)